Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Vet Clin Pathol ; 44(4): 498-502, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26356600

RESUMO

This report details a case of reversible cold agglutinins in a dog with Mycoplasma cynos pneumonia. An 11-month-old female spayed Rhodesian Ridgeback was presented for lethargy and cough. Thoracic radiographs revealed an alveolar pattern present bilaterally in the cranioventral lung lobes. Septic neutrophilic inflammation with suspected Mycoplasma sp. organisms was noted on cytologic examination of a trans-tracheal wash, and the dog was treated empirically with IV ampicillin/sulbactam and enrofloxacin pending culture results. Red blood cell agglutination was noted unexpectedly on several blood film reviews during hospitalization; however, the dog never developed clinical or laboratory evidence of hemolysis. Cold agglutinins were demonstrated based on the results of a saline dilution and cold agglutinin test that showed agglutination at 4°C but not at room temperature (21°C) or 37°C. Based on a positive culture for M cynos, the dog was treated for 8 weeks with oral enrofloxacin. After clinical and radiographic resolution of the pneumonia, repeated saline dilution and cold agglutinin tests of peripheral blood were negative at all temperatures. Reversible, asymptomatic cold agglutinins are common in human patients with mycoplasma pneumonia, but this is the first reported case in a dog.


Assuntos
Anemia Hemolítica Autoimune/veterinária , Doenças do Cão/parasitologia , Infecções por Mycoplasma/veterinária , Mycoplasma/classificação , Pneumonia Bacteriana/veterinária , Anemia Hemolítica Autoimune/parasitologia , Animais , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Doenças do Cão/sangue , Doenças do Cão/tratamento farmacológico , Doenças do Cão/etiologia , Cães , Enrofloxacina , Fluoroquinolonas/administração & dosagem , Fluoroquinolonas/uso terapêutico , Infecções por Mycoplasma/sangue , Infecções por Mycoplasma/complicações , Infecções por Mycoplasma/tratamento farmacológico , Pneumonia Bacteriana/complicações , Pneumonia Bacteriana/tratamento farmacológico , Pneumonia Bacteriana/microbiologia
2.
J Vet Cardiol ; 17(3): 182-91, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26293206

RESUMO

OBJECTIVE: To describe clinical canine patients with naturally occurring pulmonary hypertension and radiographic pulmonary alveolar infiltrates before and after treatment with sildenafil. ANIMALS: Ten client-owned dogs. METHODS: A retrospective analysis of dogs with echocardiographically-determined pulmonary hypertension and pulmonary alveolar infiltrates on thoracic radiographs was performed before (PRE) and after (POST) sildenafil therapy. Clinical scores, pulmonary alveolar infiltrate scores and tricuspid regurgitation gradients were analyzed PRE and POST sildenafil. RESULTS: Pulmonary alveolar infiltrates associated with pulmonary hypertension developed in a diffusely patchy distribution (10/10). Sixty percent of dogs had a suspected diagnosis of interstitial pulmonary fibrosis as the etiology of pulmonary hypertension. Median PRE clinical score was 4 (range: 3-4) compared to POST score of 0 (0-2) (p = 0.005). Median alveolar infiltrate score PRE was 10 (5-12) compared to POST score of 4 (0-6) (p = 0.006). Median tricuspid regurgitation gradient PRE was 83 mmHg (57-196) compared to 55 mmHg POST (33-151) (p = 0.002). CONCLUSIONS: A subset of dogs with moderate to severe pulmonary hypertension present with diffuse, patchy alveolar infiltrates consistent with non-cardiogenic pulmonary edema. The typical clinical presentation is acute dyspnea and syncope, often in conjunction with heart murmurs suggestive of valvular insufficiency. This constellation of signs may lead to an initial misdiagnosis of congestive heart failure or pneumonia; however, these dogs clinically and radiographically improve with the initiation of sildenafil.


Assuntos
Doenças do Cão/patologia , Hipertensão Pulmonar/veterinária , Alvéolos Pulmonares/patologia , Fibrose Pulmonar/veterinária , Citrato de Sildenafila/uso terapêutico , Animais , Cães , Hipertensão Pulmonar/tratamento farmacológico , Hipertensão Pulmonar/patologia , Inibidores da Fosfodiesterase 5/uso terapêutico , Fibrose Pulmonar/etiologia , Fibrose Pulmonar/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA